Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:assetsUnderManagement |
over $1.8 billion
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
healthcare services
biopharmaceuticals medical products |
| gptkbp:foundedBy |
gptkb:Alex_Denner
gptkb:Anthony_Sun gptkb:Dennis_Purcell gptkb:Steve_Elms |
| gptkbp:foundedIn |
2000
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aisling Capital
|
| gptkbp:industry |
healthcare
life sciences |
| gptkbp:investedIn |
public companies
private companies |
| gptkbp:notableInvestment |
gptkb:Trevena
gptkb:Pacira_Pharmaceuticals gptkb:Paratek_Pharmaceuticals gptkb:Zynerba_Pharmaceuticals gptkb:Durata_Therapeutics gptkb:Aimmune_Therapeutics gptkb:Ardelyx |
| gptkbp:type |
venture capital
growth equity |
| gptkbp:website |
https://www.aislingcapital.com/
|
| gptkbp:bfsParent |
gptkb:Andrew_Schiff
gptkb:Forge_Biologics |
| gptkbp:bfsLayer |
7
|